Moberg Pharma AB (publ) (STO:MOB)
9.01
-0.10 (-1.04%)
Dec 5, 2025, 5:29 PM CET
Moberg Pharma AB Revenue
Moberg Pharma AB had revenue of 4.01M SEK in the quarter ending September 30, 2025, with 3.89% growth. This brings the company's revenue in the last twelve months to 12.50M, up 42.27% year-over-year. In the year 2024, Moberg Pharma AB had annual revenue of 9.81M.
Revenue (ttm)
12.50M
Revenue Growth
+42.27%
P/S Ratio
33.87
Revenue / Employee
2.08M
Employees
10
Market Cap
423.24M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.81M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 207.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 33.66M | -16.83M | -33.33% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.67B |
| Elekta AB | 17.57B |
| Asker Healthcare Group AB | 16.41B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vitrolife AB | 3.51B |